Danish cancer vaccine patented in the US
Adaptvac, a joint venture between a Copenhagen University spinout and Danish Expres2ion, has taken out a patent in the US on a new breast cancer vaccine. "An important milestone," says the chairman.
Log in to read our articles
Welcome to MedWatch. A part of our content is exclusive and reserved for our users.
Try us for 14 days
Try a trial subscription for access to our quality journalism